19 patients report seizure freedom with medical cannabis oil treatment for drug-resistant epilepsy: a case series
The results of the study support prioritizing CBPMs in cases of DRE. It also supports research into identifying clinical and biological biomarkers for DRE cases that may achieve SF under CBPM treatment. Lastly, the study supports improving the accessibility of CBPMs, using SF as a primary outcome in future CBPM epilepsy trials, and assessing the role of THC in reducing seizures.
Authors
- Frank Yizhao Chen (ORCID: https://orcid.org/0000-0002-9817-9840)
- Brenden Samuel Rabinovitch (ORCID: https://orcid.org/0000-0003-4347-7688)
- Evan Lewis (ORCID: https://orcid.org/0000-0001-9024-150X)
- Joshua Myles Duckman
- Katrin Julia Hannesson
Institutions
- University of Toronto (CA)
- North York General Hospital (CA)
- Innovative Research Group (Canada) (CA)
- Ontario Brain Institute (CA)
Publication Details
- Journal
- Frontiers in Neuroscience
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3389/fnins.2025.1570531
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47